Recent incarceration independently associated with syringe sharing by injection drug users

Public Health Reports

Volumn 120, Issue 2, 2005, Pages 150-156

  Wood, Evan ^a,b,c   Li, Kathy ^a   Small, Will ^a   Montaner, Julio S ^a,b   Schechter, Martin T ^a,b   Kerr, Thomas ^a  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG;

ARTICLE; DEMOGRAPHY; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INJECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SYRINGE;

EID: 16844370676     PISSN: 00333549     EISSN: None     Source Type: Journal    
DOI: 10.1177/003335490512000208     Document Type: Article

References (37)

1. Beatty P, Holman B, Schiraldi V. Poor prescription: the costs of imprisoning drug offenders in the United States [cited 2004 Apr 16]. Center on Juvenile and Criminal Justice. Available from: URL: http://www.cjcj.org/pubs/ poor/pp.html
2. Tuberculosis outbreaks in prison housing units for HIV-infected inmates-California, 1995-1996. MMWR Morb Mortal Wkly Rep 1999;48:79-82.
3. Wolfe MI, Xu F, Patel P, O'Cain M, Schillinger JA, St Louis ME, Finelli L. An outbreak of syphilis in Alabama prisons: correctional health policy and communicable disease control. Am J Public Health 2001;91:1220-5.
4. Taylor A, Goldberg D, Emslie J, Wrench J, Gruer L, Cameron S, et al. Outbreak of HIV infection in a Scottish prison. BMJ 1995; 310:289-92.
5. Yirrell DL, Robertson P, Goldberg DJ, McMenamin J, Cameron S, Leigh Brown AJ. Molecular investigation into outbreak of HIV in a Scottish prison. BMJ 1997;314:1446-50.
6. Estebanez PE, Russell NK, Aguilar MD, Beland F, Zunzunegui MV. Women, drugs and HIV/AIDS: results of a multicentre European study. Int J Epidemiol 2000;29:734-43.
7. Dola KA, Wodak A. HIV transmission in a prison system in an Australian State. Med J Aust 1999;171:14-7.
8. Estebanez P, Zunzunegui MV, Aguilar MD, Russell N, Cifuentes I, Hankins C. The role of prisons in the HIV epidemic among female injecting drug users. AIDS Care 2002;14:95-104.
9. Dufour A, Alary M, Poulin C, Allard F, Noel L, Trottier G, et al. Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. AIDS 1996;10:1009-15.
10. Hankins CA, Gendron S, Handley MA, Richard C, Tung MT, O'Shaughnessy M. HIV infection among women in prison: an assessment of risk factors using a nonnominal methodology. Am J Public Health 1994;84:1637-40.
11. Rothon DA, Mathias RG, Schechter MT. Prevalence of HIV infection in provincial prisons in British Columbia. CMAJ 1994;151:781-7.
12. Correctional Services of Canada. Infectious diseases prevention and control in Canadian federal penitentiaries 2000-01 [cited 2003 Apr 16]. Available from: URL: http://www.csc-scc.gc.ca/text/pblct/infectiousdiseases/ index_e.shtml
13. Lines R. Canadian HIV/AIDS Legal Network. Action on HIV/AIDS in prisons: too little, too late: a report card [cited 2003 Apr 16]. Available from: URL: http://www.aidslaw.ca/Maincontent/issues/prisons/prison_reportcard.pdf
14. Tyndall MW, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy MV, Schechter MT. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 2003;17:887-93.
15. Hagan H. The relevance of attributable risk measures to HIV prevention planning. AIDS 2003;17:911-3.
16. Miller CL, Johnston C, Spittal PM, Li K, Laliberte N, Montaner JS, Schechter MT. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 2002;36:737-42.
17. Wood E, Kerr T, Spittal PM, Li K, Small W, Tyndall MW, et al. The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users. J Acquir Immune Defic Syndr 2003;32:2-8.
18. Diggle PJ, Liang K, Zeger S. Analysis of longitudinal data. New York: Oxford University Press; 1996.
19. Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help? CMAJ 2001;165:405-10.
20. SAS Institute, Inc. SAS: Version 8.0. Cary (NC): SAS Institute, Inc.; 1999.
21. Spittal PM, Craib KJ, Wood E, Laliberte N, Li K, Tyndall MW, et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ 2002;166:894-9.
22. Hankins C. Confronting HIV infection in prisons. CMAJ 1994; 151:743-5.
23. Dolan KA. Can hepatitis C transmission be reduced in Australian prisons? Med J Aust 2001;174:378-9.
24. Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke JG, Flanigan TP. Human immunodeficiency virus in correctional facilities: a review. Clin Infect Dis 2002;35:305-12.
25. Dolan K, Rutter S, Wodak AD. Prison-based syringe exchange programmes: a review of international research and development. Addiction 2003;98:153-8.
26. Jurgens R. HIV/AIDS in prisons: new developments. Canadian HIV/AIDS Policy and Law Newsletter 1999;4:61-6.
27. Rydell CP, Caulkins JP, Everingham SE. Enforcement or treatment? Modeling the relative efficacy of alternatives for controlling cocaine. Operations Res 1996;44:687-95.
28. Wood E, Kerr T, Spittal PM, Tyndall MW, O'Shaughnessy MV, Schechter MT. The healthcare and fiscal COSLS of the illicit drug use epidemic: the impact of conventional drug control strategies and the impact of a comprehensive approach. Br Columbia Med J 2003;45:130-6.
29. Freudenberg N. Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community health. J Urban Health 2001;78:214-35.
30. Small W, Kain S, Laliberte N, Wood E, Schechter MT, O'Shaughnessy MV, Spittal PM. Incarceration, addiction, and harm reduction: inmates' experience injecting drugs in prison. Substance Use Misuse. In press 2005.
31. Drake S. Self-report among injecting drug users: a review. Drug Alcohol Depend 1998;51:253-63.
32. Des Jarlais DC, Paone D, Milliken J, Turner CF, Miller H, Gribble J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet 1999;353:1657-61.
33. Wood E, Spittal PM, Kerr T, Small W, Tyndall MW, O'Shaughnessy MV, Schechter MT. Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can J Public Health 2003;94:355-9.
34. Craib KJ, Spittal PM, Wood E, Laliberte N, Hogg RS, Li K, et al. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ 2003;168:19-24.
35. Buavirat A, Page-Shafer K, van Griensven GJ, Mandel JS, Evans J, Chuaratanaphong J, et al. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ 2003;326:308.
36. Mahon N. New York inmates' HIV risk behaviors: the implications for prevention policy and programs. Am J Public Health 1996; 86:1211-5.
37. Wood E, Spittal P, Li K, Kerr T, Miller CL, Hogg R, et al. Inability to access addiction treatment and risk of HIV infection among injection drug users. J Acquir Immune Defic Syndr 2004;36:750-4.